Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01660009 · ClinicalTrials.gov registry record · NA

Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans

A NA study, sponsored by Medical College of Wisconsin.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT01660009 is a NA study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01660009, a NA study, was terminated before completion, sponsored by Medical College of Wisconsin.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Prior work suggests exposure to low glucose levels (hypoglycemia) is associated with increased cardiovascular risk. However, whether there is a causal relationship between cardiovascular events and hypoglycemia remains unclear with conflicting data in the literature. In this study, we plan to study whether acute exposure of patients to clinically relevant (50-60 milligrams/deciliter) levels of hypoglycemia induces or worsens blood vessel endothelial dysfunction- a key 1st step in the development of heart attacks and strokes. This will be determined in humans both with and with type 2 diabetes.

Interventions

  • OTHER Glycemic clamping

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2012-06
Est. Completion 2017-06
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT01660009

The ClinicalTrials.gov registry entry for NCT01660009 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Glycemic clamping is the first listed.

NCT01660009 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01660009 about?

NCT01660009 is a clinical study titled "Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans". Prior work suggests exposure to low glucose levels (hypoglycemia) is associated with increased cardiovascular risk. However, whether there is a causal relationship between cardiovascular events and hypoglycemia remains unclear with conflicting data in the literature. In this study, we plan to study ...

What is the current status of trial NCT01660009?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2012-06. Estimated completion is 2017-06.

What interventions are being tested in trial NCT01660009?

The interventions under investigation include: Glycemic clamping (OTHER).

Who is sponsoring clinical trial NCT01660009?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.